180 related articles for article (PubMed ID: 32222736)
1. Synchronous bilateral clear cell renal cell carcinoma and prostate gland carcinoma on
Xiao L; Zhang WJ; Ou XH; Li L
Hell J Nucl Med; 2020; 23(1):88-89. PubMed ID: 32222736
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. 2-[
Zhao Y; Wu C; Li W; Chen X; Li Z; Liao X; Cui Y; Zhao G; Liu M; Fu Z
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):570-579. PubMed ID: 32814979
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[
Wu C; Cui Y; Liu J; Ma L; Xiong Y; Gong Y; Zhao Y; Zhang X; Chen S; He Q; Zhang J; Liu M; Fan Y
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4054-4066. PubMed ID: 33978830
[TBL] [Abstract][Full Text] [Related]
6.
Qi Z; Yao X; Su M; Huang R
Hell J Nucl Med; 2023; 26(2):155-156. PubMed ID: 37527052
[TBL] [Abstract][Full Text] [Related]
7. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative
Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R
Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538
[TBL] [Abstract][Full Text] [Related]
8. Early assessment with
Tabei T; Nakaigawa N; Kaneta T; Ikeda I; Kondo K; Makiyama K; Hasumi H; Hayashi N; Kawahara T; Izumi K; Osaka K; Muraoka K; Teranishi JI; Miyoshi Y; Yumura Y; Uemura H; Kobayashi K; Inoue T; Yao M
BMC Cancer; 2019 Apr; 19(1):298. PubMed ID: 30940117
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.
Minamimoto R; Nakaigawa N; Nagashima Y; Toyohara J; Ueno D; Namura K; Nakajima K; Yao M; Kubota K
Abdom Radiol (NY); 2016 Mar; 41(3):521-30. PubMed ID: 27039323
[TBL] [Abstract][Full Text] [Related]
10. Three Primary Carcinomas on 18F-FDG PET/CT: Intrahepatic Cholangiocarcinoma, Papillary Renal Cell Carcinoma, and Clear Cell Renal Cell Carcinoma.
Wu D; Hu Y; Wei Q; Tian C; Bian Y
Clin Nucl Med; 2018 Jun; 43(6):428-430. PubMed ID: 29561526
[TBL] [Abstract][Full Text] [Related]
11. Intense Choline Activity in Renal Cell Carcinoma Without Obvious 18F-FDG Uptake.
Xia X; Hu F; Qin C; Liu F; Lan X
Clin Nucl Med; 2019 Jan; 44(1):38-39. PubMed ID: 30371589
[TBL] [Abstract][Full Text] [Related]
12. Semi-quantitative F-18-FDG PET/computed tomography parameters for prediction of grade in patients with renal cell carcinoma and the incremental value of diuretics.
Singh H; Arora G; Nayak B; Sharma A; Singh G; Kumari K; Jana S; Patel C; Pandey AK; Seth A; Kumar R
Nucl Med Commun; 2020 May; 41(5):485-493. PubMed ID: 32168262
[TBL] [Abstract][Full Text] [Related]
13. Lesion detection by [
Verhoeff SR; van Es SC; Boon E; van Helden E; Angus L; Elias SG; Oosting SF; Aarntzen EH; Brouwers AH; Kwee TC; Heskamp S; Hoekstra OS; Verheul H; van der Veldt AAM; de Vries EGE; Boerman OC; van der Graaf WTA; Oyen WJG; van Herpen CML
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1931-1939. PubMed ID: 31172212
[TBL] [Abstract][Full Text] [Related]
14. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of
Betsunoh H; Sakamoto S; Kaji Y; Nukui A; Kobayashi M; Yashi M; Hayashi K; Anzai N; Kamai T
Anticancer Res; 2021 Oct; 41(10):5179-5188. PubMed ID: 34593470
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Lee CH; Kesari V; Legesse T; Chen W
Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
[TBL] [Abstract][Full Text] [Related]
18. Increased Prostate Cancer Glucose Metabolism Detected by
Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
[TBL] [Abstract][Full Text] [Related]
19. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N
Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985
[TBL] [Abstract][Full Text] [Related]
20. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
Ge J; Zuo C; Guan Y; Liang Z
Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]